Not bad news. More like delayed news. You have to remember, that the SOC has risen since March. So we may have data that beats the EUA P factor given Gilead’s Remdesivir (what a suprise), but the DSMC says to continue. CYTODYN will know the deaths in each arm. If it is close to .005 p factor, they may elect to pay the penalty and unblind the data to shop it around the world even though the DSMC and FDA “want” full results to meet some new SOC standard. We will know by the end of the week hopefully, but I have added an extra week based on NADAR time...